Cargando…

ODP173 Control of Alpelisib-Induced Hyperglycemia With DPP4- Inhibitors as add on to Metformin and Insulin

CONTEXT: Alpelisib is an oral phosphatidylinositol-3-kinase alpha (PI3Ka) inhibitor approved in 2019 for treatment of ER/PR+, HER2-negative advanced breast cancer. The main side effect of PI3Ka inhibition is hyperglycemia. CASE: A 38 year-old woman was started on alpelisib and fulvestrant therapy fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hee, Nicholas Ken Yoong, Lim, Quan Hziung, Lim, Lee-Ling, Paramasivam, Sharmila, Vethakkan, Shireene, Chan, Siew Pheng, Ratnasingam, Jeyakantha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Diabetes & Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624781/ http://dx.doi.org/10.1210/jendso/bvac150.626

Ejemplares similares

ODP346 Prevalence and Predictors of Endocrinopathies Amongst Patients on Chronic Opioid Use for Non-Cancer Pain
por: Ooi, Xin Y, et al.
Publicado: (2022)

What Does SGLT2 Inhibition Add in Managing Hyponatremia Secondary to Syndrome of Inappropriate Antidiuresis (SIAD)?
por: Jalal, Fadzliana Hanum, et al.
Publicado: (2021)

ODP413 Impact of Gestational Weight Gain according to 2009 IOM Recommendations on Neonatal Anthropometrics in Asians: A Pilot Study from Malaysia
por: Tai, Yong Ting, et al.
Publicado: (2022)

Relationship of glycated hemoglobin, and fasting and postprandial hyperglycemia in type 2 diabetes mellitus patients in Malaysia
por: Lim, Lee Ling, et al.
Publicado: (2016)

PRKAR1A-negative familial Cushing’s syndrome: two case reports
por: Lim, Lee Ling, et al.
Publicado: (2015)

OR11-5 Early Prevalence of Neuroendocrine Dysfunction after Spontaneous Aneurysmal Subarachnoid Haemorrhage: Interim Findings from a Prospective Cohort Study
por: Chooi, Kheng Chiew, et al.
Publicado: (2019)

Alpelisib-Induced Hyperglycemia- A Small Case Series
por: Ekanayake, Preethika Subashini, et al.
Publicado: (2021)

ODP257 Alpelisib Treatment Associated With Severe Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer
por: Aziz, Shima, et al.
Publicado: (2022)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
por: Chan, Wah-Kheong, et al.
Publicado: (2023)

Diabetic Ketoacidosis With Alpelisib
por: Jeun, Rebecca, et al.
Publicado: (2021)

MON-LB128 Phosphoinositide 3-Kinase (PI3K) Inhibitor Induced Hyperglycemia With Alpelisib
por: Barsukova, Yuliya, et al.
Publicado: (2020)

Alpelisib-Induced Diabetic Ketoacidosis
por: Espinosa, Luis Borges, et al.
Publicado: (2021)

ODP243 Severe Sustained Hyperglycemia in Setting of Simultaneous Dobutamine and Insulin Infusions - Drug Interaction
por: Arora, Gunjan, et al.
Publicado: (2022)

A Case of Severe Lactation Ketoacidosis in a Nondiabetic Mother on a Ketogenic Diet
por: Borhan, Marisa Khatijah, et al.
Publicado: (2023)

ODP261 Non-Ketotic Hyperosmolar Hyperglycemia Induced Hemichorea-Dystonia Syndrome, Without Radiologic Striatopathy
por: Kumi, Dennis, et al.
Publicado: (2022)

ODP171 Choosing GLP-1RA Over Insulin for Patients with Type 2 Diabetes and Severe Hyperglycemia
por: Mamtani, Raashi, et al.
Publicado: (2022)

ODP191 Efficacy of Protocol Based Insulin Dosing in Post-Surgical Hyperglycemia Management of Kidney Transplant Recipients
por: Zia, Maryam, et al.
Publicado: (2022)

ODP227 Nivolumab Induced Type 1 Diabetes
por: Lim, Jonea, et al.
Publicado: (2022)

Alpelisib-Induced Diabetic Ketoacidosis- A Case Report
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021)

A Case of Diabetic Keto Acidosis From Alpelisib
por: Thumma, Soumya P, et al.
Publicado: (2021)

THU259 Alpelisib-induced Diabetic Ketoacidosis: Call For A Multidisciplinary Approach
por: Kalara, Niketa, et al.
Publicado: (2023)

SAT-LB031 Empagliflozin as an Add-On Medication to Subjects Uncontrolled on DPP4 Inhibitors and Metformin: Real World Data Supporting the Use of Empagliflozin as a Rational Second Add-On in Indian Type 2 Diabetic Patients
por: MS, ANEESH
Publicado: (2019)

Sliding-Scale versus Basal-Bolus Insulin in the Management of Severe or Acute Hyperglycemia in Type 2 Diabetes Patients: A Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

ODP224 Metformin Associated Lactic Acidosis in a Nondiabetic Young Female
por: Saberi, Elnaz, et al.
Publicado: (2022)

Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease
por: Oo, Mon Myat, et al.
Publicado: (2021)

MON-678 Worsening Diabetes Control in Breast Cancer Patients Treated with Alpelisib
por: Geier, Robert, et al.
Publicado: (2020)

Alpelisib Induced Hyperglycemic Ketoacidosis; Broadening the Adverse Effect Profile of an Emerging Cancer Therapy
por: Prasad, Apurwa, et al.
Publicado: (2021)

FRI610 Phosphatidylinositol 3-kinase Inhibition With Alpelisib Is Safe And Effective In Treating Refractory Hypoglycemia Associated With Malignant Insulinoma
por: Mi Kang, Yu, et al.
Publicado: (2023)

SAT173 Insulin Autoimmune Syndrome: A Rare Diagnosis With Unique Features
por: Naqvi, Syeda, et al.
Publicado: (2023)

ODP260 New Type of Autoimmune Diabetes
por: Kumar, Surina, et al.
Publicado: (2022)

ODP165 Atypical DKA? Think Cannabis!
por: Albashaireh, Arwa, et al.
Publicado: (2022)

ODP201 Fyn regulates sarcopenia via autophagy
por: Yamada, Eijiro, et al.
Publicado: (2022)

ODP186 Difficulties in diagnosing MODY: clinical case
por: Volkova, Natalya, et al.
Publicado: (2022)

ODP204 Hemochromatosis and endocrine dysfunctions – a case report
por: Carvalho, Davide, et al.
Publicado: (2022)

ODP182 Diabetes types and risk of severe COVID-19
por: Kazlauskaite, Rasa, et al.
Publicado: (2022)

ODP180 Diabetes Apps: Do They Help Our Patients?
por: Xia, Alexander, et al.
Publicado: (2022)

ODP214 INSULIN REQUIRING DIABETES MELLITUS(IRDM) and CAD
por: Singh, Santosh
Publicado: (2022)

ODP157 A Case of Pancreatic Insulinoma With Hypoglycemia Unawareneness
por: Reda, Sarah A, et al.
Publicado: (2022)

MON-173 Vitamin D And Glycemic Control In Type 2 Diabetes
por: Jadoon, Nauman, et al.
Publicado: (2019)

THU380 A Case Of Alpelisib Induced Diabetic Ketoacidosis (Dka) In A Patient With Type 2 Diabetes Mellitus And Rechallenge With SGLT2 Inhibitor
por: Sekar, Vijaykumar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1djbjrviejqt7attlb6st1ovoq